Language Select
Varian Logo

Recent News

June 19, 2018
Varian (NYSE: VAR) today announced the installation of a Varian ProBeam® cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London,... Read more
June 14, 2018
Varian (NYSE: VAR) today announced it received notification from Sirtex Medical Limited (Sirtex) on June 14, 2018 that its board has determined that the proposal from CDH Investments and China... Read more
June 11, 2018
Varian (NYSE: VAR) today announced that it will report results for the third quarter of fiscal year 2018 after market close on Wednesday, July 25, 2018. The news release will be followed by a... Read more

Recent Blog Posts

Jun 21, 2018 | Centerline
A two-part article authored by Varian-based researchers about the company’s Acuros® CTS, a software tool for scatter correction in Varian’s new Iterative cone-beam CT (CBCT) solution, was selected by... Read more
Jun 19, 2018 | Centerline
In 2017, Varian’s HyperArc™ high-definition radiotherapy was used for the first time to treat patients with brain metastases. This new technology for delivering noncoplanar stereotactic radiosurgery... Read more
Apr 06, 2018 | Centerline
The ARIA® oncology information system (OIS) version 15.5 was recently named a Category Leader in the 2018 Best in KLAS: Software and Services Report by KLAS, an independent research firm specializing... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]